Crinetics Pharmaceuticals, Inc. (CRNX)
54.94
-0.47
(-0.85%)
USD |
NASDAQ |
Jan 22, 16:00
54.94
0.00 (0.00%)
After-Hours: 20:00
Crinetics Pharmaceuticals Market Cap: 5.632B for Jan. 22, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Madrigal Pharmaceuticals, Inc. | 11.31B |
| GT Biopharma, Inc. | 7.552M |
| Axsome Therapeutics, Inc. | 9.421B |
| Sutro Biopharma, Inc. | 137.84M |
| Gossamer Bio, Inc. | 661.96M |
Market Cap Related Metrics
| PS Ratio | 3334.00 |
| PEG Ratio | -0.5517 |
| Price to Book Value | 5.253 |
| Price | 54.94 |
| Earnings Yield | -8.25% |
| PEGY Ratio | -0.5517 |